 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| BC003 / Guilin SanJin Group, CDP-1 (cetuximab biosimilar) / Guilin SanJin Group
New P1 trial, Metastases: An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor (clinicaltrials.gov) - Feb 4, 2021
P1, N=130, Recruiting, Sponsor: Dragonboat Biopharmaceutical Company Limited
- || CDP-1 (cetuximab biosimilar) / Guilin SanJin Group
New P1 trial, Preclinical, Metastases: Phase I Clinical Trial of CDP1 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Nov 14, 2019
P1, N=30, Not yet recruiting, Sponsor: Dragonboat Biopharmaceutical Company Limited
- || CDP-1 (cetuximab biosimilar) / Guilin SanJin Group
Enrollment closed, Metastases: A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC (clinicaltrials.gov) - Nov 8, 2019
P1, N=18, Active, not recruiting, Sponsor: Dragonboat Biopharmaceutical Company Limited
Recruiting --> Active, not recruiting
- || CDP-1 (cetuximab biosimilar) / Guilin SanJin Group
Enrollment open, Trial completion date, Trial primary completion date, Metastases: A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC (clinicaltrials.gov) - Mar 20, 2019
P1, N=16, Recruiting, Sponsor: Dragonboat Biopharmaceutical Company Limited
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Trial completion date: Jun 2019 --> Dec 2019 | Trial primary completion date: Jan 2019 --> Sep 2019
- ||| CDP-1 (cetuximab biosimilar) / Guilin SanJin Group
New P1 trial: Clinical Trial to Evaluate Pharmacokinetics,Safety and Immunogenicity of Single Injection of CDP1 to Healthy Volunteers Compared to Erbitux (clinicaltrials.gov) - Mar 20, 2019
P1, N=84, Recruiting, Sponsor: Dragonboat Biopharmaceutical Company Limited
- | CDP-1 (cetuximab biosimilar) / Guilin SanJin Group
New P1 trial, Metastases: A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC (clinicaltrials.gov) - Apr 8, 2018
P1, N=16, Not yet recruiting, Sponsor: Dragonboat Biopharmaceutical Company Limited